NH TherAguix Competitors and Similar CompaniesClear all
NH TherAguix's competitors and similar companies include Tetherex, Medivir, Shanghai Henlius Biotech and Elicio Therapeutics.
 NH TherAguix NH TherAguix is a clinical stage company, specializing in nanomedicine for cancer radiotherapy. |  Tetherex Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases. |  Medivir Medivir is a company that researches, develops, and sells pharmaceuticals primarily for the treatment of oncology. |  Shanghai Henlius Biotech Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
|  Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. | |
Founding Date | Founding Date 2015 | Founding Date 2014 | Founding Date 1988 | Founding Date 2009 | Founding Date 2011 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Villeurbanne, FR HQ | Locations Oklahoma City, US HQ Morrisville, US | Locations Huddinge, SE HQ | Locations HQ | Locations Cambridge, US HQ |
Employees | Employees 1910% decrease | Employees N/A | Employees 9 | Employees 1273% increase | Employees 22 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 39.2 m | Valuation ($) N/A | Valuation ($) 47.5 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income (kr94.4m) (FY, 2025) | Net income N/A | Net income ($39.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 14.6m (about 7 years ago) | Latest funding round $ 43m (about 8 years ago) | Latest funding round N/A | Latest funding round $ 156m (almost 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 14.6m | Total funding raised $ 46.2m | Total funding raised N/A | Total funding raised $ 346m | Total funding raised $ 150.3m |
For sources of this data, please see the company profile
View Company Profiles
Tetherex
HQ
Oklahoma City, US
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
View companyMedivir
HQ
Huddinge, SE
Employees
9
Medivir is a company that researches, develops, and sells pharmaceuticals primarily for the treatment of oncology.
View companyShanghai Henlius Biotech
HQ
Employees
127↑ 3% increase
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
View companyElicio Therapeutics
HQ
Cambridge, US
Employees
22
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View company